STGW’s (STGW) Annual Fierce Pharma PR & Communications Summit Is Sponsored by the Harris Poll of Stagwell (STGW)

July 15, 2022
STGW’s (STGW) Annual Fierce Pharma PR & Communications Summit Is Sponsored by the Harris Poll of Stagwell (STGW)
The Harris Poll, a Stagwell (NASDAQ: STGW) agency, is proud to be a sponsor of the 2022 17th Annual Fierce Pharma PR & Communications Summit, the premier event dedicated to providing life science.

The Harris Poll, a Stagwell (NASDAQ: STGW) agency, is proud to be a sponsor of the 2022 17th Annual Fierce Pharma PR & Communications Summit, the premier event dedicated to providing life science communicators with industry updates and best practices for successful communications strategies in today’s complex healthcare environment. The summit will be held July 19 and 20 in Jersey City, NJ.

“The Pharma PR summit is such a valuable conference for healthcare communicators, marketers, policy makers, and advocates and one I’m always happy to support and participate in,” said Kathy Steinberg, Vice President at The Harris Poll and Advisory Board member for Fierce Pharma. “In an increasingly fragmented and complicated media landscape, I think it’s more important than ever for data-driven thought leadership to be a core feature of how players in the healthcare space communicate with their many and varied stakeholders.”

Three representatives from The Harris Poll’s Media Communications Research and Reputation practices will present at the summit:

  • Steinberg, Vice President and Advisory Board member for Fierce Pharma, moderating, “Digital First & Data Driven Communications Best Practices” on Day 1 of the conference;
  • Michele Salomon, Vice President, moderating “Combating Misinformation and Bias in Healthcare Communications,” also on Day 1; and,
  • Rob Jekielek, Managing Director, who will lead, “Pharma Reputation: Fighting the Fade with Purposeful Pivots” on Day 2 of the conference.

Jekielek will present the latest Harris Poll data tracking the Pharma industry’s reputation from The Axios-Harris Poll 100 (Harris Poll’s 23rd Annual RQ Study). Additionally, insights from key HCP/ healthcare experts will be shared to understand today’s marketplace more fully. This data-driven session will look at the incredible evolution of corporate reputation in the pharma and biotech industries from well before COVID to today.

The Harris Poll will also share new research, conducted among a nationally representative sample of over 2,000 U.S. adults, to understand health information sources and the role they play in supporting patients in managing their health as well as facilitating their relationship with their healthcare providers. The research includes a comparison of the public’s trust in health-related information sources from 2019 to 2022.

The Harris Poll has been a sponsor of the Fierce Pharma PR Summit for four years.